$RVYL
RYVYL Inc. Stock $rvyl

$rvyl Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000118518522001331 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$10.42M	$10.63M	$8.045M
YoY Change	46.13%	32.12%	162.92%
Cost Of Revenue	$5.810M	$4.270M	$2.421M
YoY Change	42.6%	76.37%	30.85%
Gross Profit	$4.610M	$6.360M	$5.625M
YoY Change	50.84%	13.08%	364.85%
Gross Profit Margin	44.24%	59.83%	69.91%
Selling, General & Admin	$7.420M	$5.680M	$6.877M
YoY Change	-24.96%	-17.41%	468.38%
% of Gross Profit	160.95%	89.31%	122.27%
Research & Development	$980.0K	$1.442M	$1.043M
YoY Change	-28.21%	38.21%	334.75%
% of Gross Profit	21.26%	22.67%	18.55%
Depreciation & Amortization	$16.20M	$35.22K	$464.5K
YoY Change	3625.94%	-92.42%	4545.5%
% of Gross Profit	351.41%	0.55%	8.26%
Operating Expenses	$24.43M	$9.423M	$8.378M
YoY Change	109.01%	12.47%	477.82%
Operating Profit	-$19.82M	-$3.063M	-$2.754M
YoY Change	129.6%	11.23%	1047.36%
Interest Expense	-$3.800M	$907.0K	-$4.740K
YoY Change	97.62%	-19234.22%	-98.03%
% of Operating Profit
Other Income/Expense, Net	$420.0K	$0.00	-$37.50K
YoY Change	54.75%	-100.0%	275.0%
Pretax Income	-$23.21M	-$15.14M	-$2.796M
YoY Change	125.7%	441.35%	470.59%
Income Tax	-$50.00K	$34.79K	$3.254M
% Of Pretax Income
Net Earnings	-$23.16M	-$15.17M	-$6.050M
YoY Change	229.22%	150.76%	1134.64%
Net Earnings / Revenue	-222.26%	-142.72%	-75.19%
Basic Earnings Per Share
Diluted Earnings Per Share	-$4.63	-$3.22	-$143.8K
COMMON SHARES
Basic Shares Outstanding	49.65M shares	44.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.00M	$11.00M	$29.71M
YoY Change	-84.37%	-62.97%
Cash & Equivalents	$13.96M	$11.02M	$29.71M
Short-Term Investments
Other Short-Term Assets	$7.427M	$855.1K	$261.0K
YoY Change	908.77%	227.69%	44.98%
Inventory	$302.0K	$273.7K	$177.8K
Prepaid Expenses
Receivables	$1.156M	$790.1K	$3.019M
Other Receivables	$7.400M	$22.20M	$19.42M
Total Short-Term Assets	$59.22M	$68.38M	$52.58M
YoY Change	-48.81%	30.05%	507.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.696M	$1.702M	$2.299M
YoY Change	1.24%	-25.97%	994.88%
Goodwill	$26.75M	$26.63M
YoY Change	342.34%
Intangibles	$6.739M	$22.39M
YoY Change	-11.09%
Long-Term Investments	$1.500M	$1.500M
YoY Change
Other Assets	$196.9K	$186.0K	$198.0K
YoY Change	3.27%	-6.02%	119.94%
Total Long-Term Assets	$38.44M	$54.02M	$16.54M
YoY Change	126.35%	226.6%	5413.04%
TOTAL ASSETS
Total Short-Term Assets	$59.22M	$68.38M	$52.58M
Total Long-Term Assets	$38.44M	$54.02M	$16.54M
Total Assets	$97.66M	$122.4M	$69.12M
YoY Change	-26.39%	77.08%	671.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.50M	$22.70M	$7.436M
YoY Change	419.69%	205.27%	-44.3%
Accrued Expenses	$2.300M	$600.0K	$375.5K
YoY Change	33.61%	59.79%	212.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$12.87K	$276.2K
YoY Change		-95.34%	-62.17%
Long-Term Debt Due	$0.00	$12.87K	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$36.74M	$27.27M	$11.67M
YoY Change	36.94%	133.66%	-19.89%
LONG-TERM LIABILITIES
Long-Term Debt	$61.73M	$637.0K	$645.1K
YoY Change	9399.09%	-1.26%
Other Long-Term Liabilities	$1.100M	$1.100M	$294.5K
YoY Change	6.19%	273.53%	145.41%
Total Long-Term Liabilities	$61.73M	$637.0K	$939.6K
YoY Change	9399.09%	-32.2%	683.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.74M	$27.27M	$11.67M
Total Long-Term Liabilities	$61.73M	$637.0K	$939.6K
Total Liabilities	$99.58M	$87.70M	$12.61M
YoY Change	14.24%	595.37%	-14.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.77M	-$64.25M	-$35.21M
YoY Change	161.33%	82.47%
Common Stock	$49.02K	$48.16K
YoY Change	14.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$2.680M
YoY Change	-100.0%	-100.0%
Treasury Stock Shares		0.000 shares
Shareholders Equity	-$1.923M	$34.71M	$56.51M
YoY Change
Total Liabilities & Shareholders Equity	$97.66M	$122.4M	$69.12M
YoY Change	-26.39%	77.08%	671.45%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$23.16M	-$15.17M	-$6.050M
YoY Change	229.22%	150.76%	1134.64%
Depreciation, Depletion And Amortization	$16.20M	$35.22K	$464.5K
YoY Change	3625.94%	-92.42%	4545.5%
Cash From Operating Activities	$150.0K	-$14.54M	$1.125M
YoY Change	-101.14%	-1392.44%	-287.5%
INVESTING ACTIVITIES
Capital Expenditures	$60.00K	-$150.0K	-$29.41K
YoY Change	-198.3%	410.03%
Acquisitions
YoY Change
Other Investing Activities	-$730.0K	-$1.450M	$0.00
YoY Change
Cash From Investing Activities	-$790.0K	-$1.300M	-$29.41K
YoY Change	1194.23%	4320.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$1.535M
YoY Change			89.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-820.0K	0.000	-1.185M
YoY Change	-101.12%	-100.0%	-6025.45%
NET CHANGE
Cash From Operating Activities	150.0K	-14.54M	1.125M
Cash From Investing Activities	-790.0K	-1.300M	-29.41K
Cash From Financing Activities	-820.0K	0.000	-1.185M
Net Change In Cash	-1.460M	-15.84M	-89.50K
YoY Change	-102.44%	17598.32%	-84.57%
FREE CASH FLOW
Cash From Operating Activities	$150.0K	-$14.54M	$1.125M
Capital Expenditures	$60.00K	-$150.0K	-$29.41K
Free Cash Flow	$90.00K	-$14.39M	$1.154M
YoY Change	-100.69%	-1346.52%	-292.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity File Number EntityFileNumber	001-34294
	dei	Entity Registrant Name EntityRegistrantName	RYVYL Inc.
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3962936
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3131 Camino Del Rio North, Suite 1400
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92108
	dei	City Area Code CityAreaCode	(619)
	dei	Local Phone Number LocalPhoneNumber	631-8261
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	RVYL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49647531	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11020840	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89559695	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	26606827	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54795	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54795	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	790069	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	481668	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3127	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3127	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	273684	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	286360	usd
CY2022Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	3904952	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	3904952	usd
CY2022Q3	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	15125184	usd
CY2021Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	18941761	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14567792	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6420696	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	68384396	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	115690180	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1702172	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1674884	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186038	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	190636	usd
CY2022Q3	us-gaap	Goodwill Goodwill	26625946	usd
CY2021Q4	us-gaap	Goodwill Goodwill	6048034	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22394833	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7578935	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1656448	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1490159	usd
CY2022Q3	us-gaap	Investments Investments	1451247	usd
CY2021Q4	us-gaap	Investments Investments	0	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	54016684	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	16982648	usd
CY2022Q3	us-gaap	Assets Assets	122401080	usd
CY2021Q4	us-gaap	Assets Assets	132672828	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	97183	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	871037	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1408410	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	501167	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	8022	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1226287	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22593376	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4997807	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	12870	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2520127	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	18735000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	632038	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	495134	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27272026	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26826432	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	637030	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	649900	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	30241836	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-708424	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	41344822	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	58661454	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	58655178	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1124624	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1035895	usd
CY2022Q3	us-gaap	Liabilities Liabilities	87695134	usd
CY2021Q4	us-gaap	Liabilities Liabilities	87167405	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	42831	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	rvyl	Common Stock Issuable Shares Issuable CommonStockIssuableSharesIssuable	2516189	shares
CY2021Q4	rvyl	Common Stock Issuable Shares Issuable CommonStockIssuableSharesIssuable	0	shares
CY2022Q3	rvyl	Common Stock Issuable CommonStockIssuable	2412	usd
CY2021Q4	rvyl	Common Stock Issuable CommonStockIssuable	0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99618045	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	88574469	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	82500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	82500000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48499026	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48499026	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42831816	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42831816	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	48155	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64254242	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38178061	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	714831	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4933816	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34705946	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45505423	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	122401080	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132672828	usd
CY2022Q3	us-gaap	Revenues Revenues	10629691	usd
CY2021Q3	us-gaap	Revenues Revenues	8045469	usd
	us-gaap	Revenues Revenues	22490824	usd
	us-gaap	Revenues Revenues	19174089	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	4269529	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	2420748	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10976255	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5337999	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	6360162	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	5624721	usd
	us-gaap	Gross Profit GrossProfit	11514569	usd
	us-gaap	Gross Profit GrossProfit	13836090	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	438523	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	37179	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1106341	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4736	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5662463	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-598994	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	338348	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	84509	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1442038	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1043385	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10418996	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2298849	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	457633	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4879798	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5300115	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2504976	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186123	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	784158	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	477886	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9422953	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	8378388	usd
	us-gaap	Operating Expenses OperatingExpenses	29531534	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4331918	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1648383	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2384544	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1250451	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7480377	usd
	us-gaap	Operating Expenses OperatingExpenses	25988399	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3062791	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2753667	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18016965	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12152309	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1906962	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2871581	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	1031867	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	789772	usd
	us-gaap	Professional Fees ProfessionalFees	3704226	usd
	us-gaap	Professional Fees ProfessionalFees	2114996	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2021Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3777572	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	166800	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	5867072	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	508313	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2223611	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	132696	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	238238	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	436817	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	11539803	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2993408	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-4082056	usd
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14591938	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-5709672	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-5709672	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Other Expenses OtherExpenses	364124	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	62806	usd
CY2021Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-37497	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	298021	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-56057	usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses	0	usd
CY2021Q3	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
CY2022Q3	rvyl	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.32
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12072701	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-42233	usd
CY2021Q3	rvyl	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.14
	rvyl	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.59
	rvyl	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.49
CY2022Q3	rvyl	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	47104952	shares
CY2021Q3	rvyl	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	42065842	shares
	rvyl	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	44072798	shares
	rvyl	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	39949732	shares
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8021979	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4012583	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15135492	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2795900	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26038944	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16164892	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34785	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3253855	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37237	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3253855	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-15170277	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6049755	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26076181	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19418747	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-15170277	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6049755	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26076181	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19418747	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-310585	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-708424	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15480862	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6049755	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26784605	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19418747	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	39949335	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	132696	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	459349	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	48	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	7826135	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-310585	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-15170277	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34705946	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45505423	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	338348	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1956060	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5215	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	48	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2110000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12826135	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3236723	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	166800	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-708424	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26076181	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34705946	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	47931461	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	211201	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	164912	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	82504	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	12140000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-843	usd
CY2021Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1746290	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6049755	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	56510762	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	385236	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3731200	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3850000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10427836	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2250	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5867073	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4194000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2679933	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	12140000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19418747	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	56510762	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-26076181	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19418747	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4718262	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	477886	usd
	rvyl	Noncash Lease Expense NoncashLeaseExpense	-54117	usd
	rvyl	Noncash Lease Expense NoncashLeaseExpense	1202	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	166800	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	5867072	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-338348	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-10418996	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1819341	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	598994	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2223611	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	11539803	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2993408	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	14591938	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-5709672	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-25906	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	308401	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	154556	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12676	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53278	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1903359	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	184172	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-3816577	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	12114404	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-47644	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-679558	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-728041	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	370487	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	347718	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3384258	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1218265	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2561645	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6898339	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11444065	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14034039	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101798	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97818	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	1451247	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	500000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46863645	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2597818	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	3236723	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	2679633	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5215	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2250	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	6000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3731200	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4194000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45805491	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9231508	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43015308	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-1491068	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	18676860	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48862358	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27874519	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3069670	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89559695	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1832735	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37627667	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29707254	usd
	us-gaap	Interest Paid InterestPaid	4907111	usd
	us-gaap	Interest Paid InterestPaid	4639	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	12826135	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	3850000	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	12140000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	594355	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
	us-gaap	Basis For Attributing Revenues From External Customers To Individual Countries BasisForAttributingRevenuesFromExternalCustomersToIndividualCountries	revenues from two geographic areas, consisting of North America and Europe
CY2022Q3	us-gaap	Revenues Revenues	10629691	usd
CY2021Q3	us-gaap	Revenues Revenues	8045469	usd
	us-gaap	Revenues Revenues	22490824	usd
	us-gaap	Revenues Revenues	19174089	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	24097005	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	9253819	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with the GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	2.0002	pure
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11020840	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89559695	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	26606827	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37627667	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89559695	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	2520127	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	18735000	usd
	rvyl	Covid19 Update Textblock COVID19UpdateTextblock	<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:top;width:1.3%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>3. </b></p> </td> <td style="vertical-align:top;width:20.1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COVID-19 UPDATE</b></p> </td> </tr> </table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In December 2019, a novel strain of coronavirus (“COVID-19”) was identified and the disease has since spread across the world. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains, and created significant volatility and disruption in the financial and capital markets. The full extent to which the COVID-19 outbreak will impact the Company’s business, results of operations, financial condition and cash flows will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning COVID-19 and the actions to contain or treat its impact and the economic impact and the economic impact on local, regional, national and international markets. As the COVID-19 pandemic continues, the Company’s results of operations, financial condition and cash flows may be materially adversely affected, particularly if the pandemic persists for a significant period of time.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On March 27, 2020<i>, </i>the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law. The Act includes provisions relating to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. These provisions are not expected to have a material effect on the Company’s unaudited consolidated financial statements.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On April 29, 2020, the Company entered into a loan agreement with Preferred Bank under Paycheck Protection Program administered by SBA in the amount of $272,713. Under this loan program, the loan may be forgiven if utilized for specific purpose specified under the CARES Act and PPP guideline. The loan bears interest of 1.00% per annum and matures on April 29, 2022. The loan was forgiven on November 8, 2021.</p>
CY2020Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	272713	usd
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2022Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	450251	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	76127	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	685332	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	usd
CY2022Q3	us-gaap	Notes Receivable Net NotesReceivableNet	6410000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	5590000	usd
CY2022Q3	us-gaap	Deposit Contracts Assets DepositContractsAssets	6148756	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	18316	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	18316	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	855137	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	736253	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14567792	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6420696	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1887138	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1757516	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	184966	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82632	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1702172	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1674884	usd
CY2022Q3	us-gaap	Depreciation Depreciation	35217	usd
CY2021Q3	us-gaap	Depreciation Depreciation	79873	usd
	us-gaap	Depreciation Depreciation	102334	usd
	us-gaap	Depreciation Depreciation	93211	usd
CY2022Q3	us-gaap	Goodwill Goodwill	26625946	usd
CY2021Q4	us-gaap	Goodwill Goodwill	6048034	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	500000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27871827	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5458444	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22394833	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8431283	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	852348	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7578935	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2110815	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	431936	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	464646	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	438851	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2092267	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8369068	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7894024	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3208176	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	831298	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22394833	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	649900	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	649900	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	12870	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	637030	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	649900	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000000	usd
CY2021Q4	rvyl	Debt Issuance Costs Gross Percent DebtIssuanceCostsGrossPercent	0.16	pure
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	16000000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q4	rvyl	Debt Default Interest Rate DebtDefaultInterestRate	0.15	pure
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	436817	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	11539803	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	906962	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	662463	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	900000	usd
CY2022Q3	rvyl	Debt Amendment Description DebtAmendmentDescription	On August 16, 2022, we and the Investor entered into a Restructuring Agreement (the “Restructuring Agreement”) that had the following major provisions: a) the Investor agreed to forbear from requiring the repayment of the Note (to the extent such repayment obligation arises solely as a result of the occurrence of the maturity date and not with respect to any event of default or redemption right in the Note or pursuant to the First Indenture) during the period commencing on November 5, 2023 through, and including, November 5, 2024; b) with respect to interest dates on and after October 3, 2022, subject to the satisfaction of certain equity conditions, unless the Company delivers a written notice to the Investor specifying that the interest due on such interest date shall be paid in cash, on the applicable interest date, the Company shall issue shares of its common stock, solely with respect to such applicable interest due on such interest date, at a conversion price equal to 95% of the lower of (i) the then in effect conversion price and (ii) the lowest volume weighted average price of our common stock during the five trading days immediately prior to such conversion; c) the Company and the Investor agreed that, effective as of August 16, 2022, the Investor would convert $500,000 of principal (together with any accrued and unpaid interest thereon) of the Note into shares of the Company’s common stock at a conversion price equal to the lower of (i) the then in effect conversion price and (ii) the lowest volume weighted average price of our common stock during the five trading days immediately prior to such conversion. The Investor received 495,099 shares of common stock as a result of the conversion price equaling $1.02. d) the Company and the Investor agreed that, with respect to each conversion after August 16, 2022, but not in excess of $4.5 million of principal (together with any accrued and unpaid interest thereon) of the Note, in the aggregate (excluding any interest converted in accordance with the Restructuring Agreement), on each applicable conversion date, the conversion price will equal the lesser of (i) $2.40 and (ii) 97.5% of the lower of (x) the then in effect conversion price and (y) the lowest volume weighted average price of our common stock during the five trading days immediately prior to such conversion; and e) with respect to the Company’s proposed amendment of its Amended and Restated Articles of Incorporation and Amended and Restated By-laws with respect to and in connection with the Company’s proposed name change and increase in the number of authorized shares of the Company (the “Voting Proposal”), the Investor agreed to vote any shares of common stock held by it on the record date of the Voting Proposal in favor of the Voting Proposal.
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	8635333	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	5986954	shares
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.44
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5709672	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	Pursuant to the terms of the Restructuring Agreement, the investor can convert up to another $1,450,000 of the Note at a conversion price that is the lower of (i) $2.40 and (ii) 97.5% of the lower of (x) the then in effect conversion price and (y) the lowest volume weighted average price of our common stock during the five trading days immediately prior to such conversion.Thereafter, if the Company’s common stock closing price remains under $5.50 (prior to November 8, 2022) or $6.50 (on and after November 8, 2022), the investor can convert up to another $20,000,000 of the note at a conversion price that is the lower of (i) the then in effect conversion price and (ii) the greater of (x) the Note’s $1.67 floor price or (y) 98% of the market price on the conversion date.
CY2021Q4	rvyl	Debt Late Charge Percentage DebtLateChargePercentage	0.15	pure
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	18735000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-14591938	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	-1622935	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	2520127	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	477430	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	230122	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.59
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	100802	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	31251	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.5
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	575499	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.06
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6865703	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	446295	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.37
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5324299	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	547834	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.8
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6535660	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	391562	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12417	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9702	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.24
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	369443	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.47
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	369443	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.47
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	369443	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.47
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	39413	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	39413	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	232892	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	171883	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	586607	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	272672	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	700833	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	222500	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	221090	shares
CY2021Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	18489207	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5590000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1000000	shares
CY2022Q3	us-gaap	Share Price SharePrice	0.82
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	193151	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	671630	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	462452	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	350422	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	248605	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	42464	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2008465	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	251803	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1756662	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	632038	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1124624	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Central Index Key EntityCentralIndexKey	0001419275

Files In Submission

Name	View Source	Status
rvyl-20220930_cal.xml	Edgar Link	unprocessable
0001185185-22-001331-index-headers.html	Edgar Link	pending
0001185185-22-001331-index.html	Edgar Link	pending
0001185185-22-001331.txt	Edgar Link	pending
0001185185-22-001331-xbrl.zip	Edgar Link	pending
ex_448330.htm	Edgar Link	pending
ex_448331.htm	Edgar Link	pending
ex_448332.htm	Edgar Link	pending
ex_448333.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
greenbox20220930_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
greenbox20220930_10q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rvyl-20220930.xsd	Edgar Link	pending
rvyl-20220930_def.xml	Edgar Link	unprocessable
rvyl-20220930_lab.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
rvyl-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RVYL
RYVYL Inc. Stock $rvyl

2022 Q4 Form 10-Q Financial Statement

#000118518522001331 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVYL RYVYL Inc. Stock $rvyl

2022 Q4 Form 10-Q Financial Statement

#000118518522001331 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVYL
RYVYL Inc. Stock $rvyl